Metformin is a highly effective medication for managing type 2 diabetes mellitus. Recent studies have shown that it has significant therapeutic benefits in various organ systems, particularly the liver. Although the effects of metformin on metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis are still being debated, it has positive effects on cirrhosis and anti-tumoral properties, which can help prevent the development of hepatocellular carcinoma. Furthermore, it has been proven to improve insulin resistance and dyslipidaemia, commonly associated with liver diseases. While more studies are needed to fully determine the safety and effectiveness of metformin use in liver diseases, the results are highly promising. Indeed, metformin has a terrific potential for extending its full therapeutic properties beyond its traditional use in managing diabetes.

Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D'Avino, M., et al. (2024). Metformin and the Liver: Unlocking the Full Therapeutic Potential. METABOLITES, 14(4), 1-16 [10.3390/metabo14040186].

Metformin and the Liver: Unlocking the Full Therapeutic Potential

Perazza, Federica;Leoni, Laura;Colosimo, Santo;Musio, Alessandra;Bocedi, Giulia;Agnelli, Giulio;Nicastri, Alba;Rossetti, Chiara;Sacilotto, Federica;Marchesini, Giulio;Petroni, Maria Letizia;Ravaioli, Federico
2024

Abstract

Metformin is a highly effective medication for managing type 2 diabetes mellitus. Recent studies have shown that it has significant therapeutic benefits in various organ systems, particularly the liver. Although the effects of metformin on metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis are still being debated, it has positive effects on cirrhosis and anti-tumoral properties, which can help prevent the development of hepatocellular carcinoma. Furthermore, it has been proven to improve insulin resistance and dyslipidaemia, commonly associated with liver diseases. While more studies are needed to fully determine the safety and effectiveness of metformin use in liver diseases, the results are highly promising. Indeed, metformin has a terrific potential for extending its full therapeutic properties beyond its traditional use in managing diabetes.
2024
Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D'Avino, M., et al. (2024). Metformin and the Liver: Unlocking the Full Therapeutic Potential. METABOLITES, 14(4), 1-16 [10.3390/metabo14040186].
Perazza, Federica; Leoni, Laura; Colosimo, Santo; Musio, Alessandra; Bocedi, Giulia; D'Avino, Michela; Agnelli, Giulio; Nicastri, Alba; Rossetti, Chia...espandi
File in questo prodotto:
File Dimensione Formato  
metabolites-14-00186-with-cover.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 683.53 kB
Formato Adobe PDF
683.53 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/973715
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact